See also: Generic Aricept ODT
Aricept is a brand name of donepezil, approved by the FDA in the following formulation(s):
ARICEPT (donepezil hydrochloride - tablet; oral)
Manufacturer: EISAI INC
Approval date: November 25, 1996
Strength(s): 10MG [RLD][AB], 5MG [AB]
Manufacturer: EISAI INC
Approval date: July 23, 2010
Strength(s): 23MG [RLD]
Has a generic version of Aricept been approved?
A generic version of Aricept has been approved by the FDA. However, this does not mean that the product will necessarily be commercially available - possibly because of drug patents and/or drug exclusivity. The following products are equivalent to Aricept and have been approved by the FDA:
donepezil hydrochloride tablet; oral
Manufacturer: ACCORD HLTHCARE
Approval date: August 29, 2011
Strength(s): 10MG [AB], 5MG [AB]
Manufacturer: ACTAVIS PHARMA
Approval date: May 31, 2011
Strength(s): 10MG [AB], 5MG [AB]
Manufacturer: APOTEX
Approval date: June 2, 2011
Strength(s): 10MG [AB], 5MG [AB]
Manufacturer: AUROBINDO
Approval date: May 31, 2011
Strength(s): 10MG [AB], 5MG [AB]
Manufacturer: CIPLA LTD
Approval date: May 31, 2011
Strength(s): 10MG [AB], 5MG [AB]
Manufacturer: DR REDDYS LABS LTD
Approval date: May 31, 2011
Strength(s): 10MG [AB], 5MG [AB]
Manufacturer: HIKMA PHARMS
Approval date: May 31, 2011
Strength(s): 10MG [AB], 5MG [AB]
Manufacturer: HUAHAI US INC
Approval date: May 31, 2011
Strength(s): 10MG [AB], 5MG [AB]
Manufacturer: JUBILANT LIFE
Approval date: May 31, 2011
Strength(s): 10MG [AB], 5MG [AB]
Manufacturer: MATRIX LABS LTD
Approval date: May 31, 2011
Strength(s): 10MG [AB], 5MG [AB]
Manufacturer: PLIVA HRVATSKA DOO
Approval date: May 31, 2011
Strength(s): 10MG [AB], 5MG [AB]
Manufacturer: RANBAXY
Approval date: November 26, 2010
Strength(s): 10MG [AB], 5MG [AB]
Manufacturer: ROXANE
Approval date: May 31, 2011
Strength(s): 10MG [AB], 5MG [AB]
Manufacturer: SANDOZ
Approval date: May 31, 2011
Strength(s): 10MG [AB], 5MG [AB]
Manufacturer: SUN PHARM INDS
Approval date: May 31, 2011
Strength(s): 10MG [AB], 5MG [AB]
Manufacturer: TEVA
Approval date: May 31, 2011
Strength(s): 10MG [AB], 5MG [AB]
Manufacturer: TORRENT PHARMS
Approval date: May 31, 2011
Strength(s): 10MG [AB], 5MG [AB]
Manufacturer: WOCKHARDT
Approval date: May 31, 2011
Strength(s): 10MG [AB], 5MG [AB]
Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Aricept. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.
See also: About generic drugs.
Related Patents
Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.
Polymorphs of donepezil hydrochloride and process for production
Patent 5,985,864
Issued: November 16, 1999
Inventor(s): Imai; Akio & Watanabe; Hideaki & Kajima; Takashi & Ishihama; Yasushi & Ohtsuka; Akiyo & Tanaka; Tomohide & Narabu; Yukio
Assignee(s): Eisai Co., Ltd.
Donepezil hydrochloride, 1-benzyl-4-[(5,6-dimethoxy-1-indanon)-2-yl]methylpiperidine hydrochloride, is provided here in the form of four polymorphs which are stable against heat and humidity in the pharmaceutical use. They can be industrially produced. They are specified by peaks in X-ray powder diffraction pattern and absorption peaks in infrared absorption spectra in potassium bromide.Patent expiration dates:
- December 30, 2016
- December 30, 2016
Polymorphs of donepezil hydrochloride and process for production
Patent 6,140,321
Issued: October 31, 2000
Inventor(s): Imai; Akio & Watanabe; Hideaki & Kajima; Takashi & Ishihama; Yasushi & Ohtsuka; Akiyo & Tanaka; Tomohide
Assignee(s): Eisai Co., Ltd.
Donepezil hydrochloride, 1-benzyl-4-[(5,6-dimethoxy-1-indanon)-2-yl]methylpiperidine hydrochloride, is provided here in the form of four polymorphs which are stable against heat and humidity in the pharmaceutical use. They can be industrially produced. They are specified by peaks in X-ray powder diffraction pattern and absorption peaks in infrared absorption spectra in potassium bromide.Patent expiration dates:
- December 30, 2016
- December 30, 2016
Donepezil polycrystals and process for producing the same
Patent 6,245,911
Issued: June 12, 2001
Inventor(s): Imai; Akio & Ichinohe; Toshiyuki & Endo; Takashi & Tsurugi; Tomio & Uemura; Makoto
Assignee(s): Eisai Co., Ltd.
The present invention provides novel polymorphic crystals (A) to (C) having excellent handling properties and an extremely low content of residual solvent of donepezil used as a precursor for production of donepezil hydrochloride having an excellent action as a medicament, and an industrial process for producing the same. Further, the novel polymorphic crystals (A) to (C) according to the present invention are characterized by the powder X-ray diffraction pattern and/or IR absorption peaks of donepezil represented by the following formula: ##STR1##Patent expiration dates:
- December 1, 2018
- December 1, 2018
Stabilized composition comprising antidementia medicament
Patent 6,372,760
Issued: April 16, 2002
Inventor(s): Akira; Kato & Tsutomu; Harada & Naokazu; Murahashi & Yukiko; Sugaya & Hidenobu; Ando
Assignee(s): Eisai Co., Ltd.
The present invention provides a stable composition of an antidementia medicament. Specifically, it is a stabilized composition of an antidementia medicament comprising an antidementia medicament and an organic acid. As the organic acid, tosyllic acid, mesyllic acid, benzoic acid, salicylic acid, tartaric acid, citric acid and the like are particularly preferable.Patent expiration dates:
- March 31, 2019✓
- March 31, 2019
Related Exclusivities
Exclusivity is exclusive marketing rights granted by the FDA upon approval of a drug and can run concurrently with a patent or not. Exclusivity is a statutory provision and is granted to an NDA applicant if statutory requirements are met.
- Exclusivity expiration dates:
- July 23, 2013 - NEW PRODUCT
See also...
- Aricept Consumer Information (Drugs.com)
- Aricept Consumer Information (Wolters Kluwer)
- Aricept Consumer Information (Cerner Multum)
- Aricept Advanced Consumer Information (Micromedex)
- Aricept AHFS DI Monographs (ASHP)
- Donepezil Consumer Information (Wolters Kluwer)
- Donepezil Orally Disintegrating Tablets Consumer Information (Wolters Kluwer)
- Donepezil Consumer Information (Cerner Multum)
- Donepezil Advanced Consumer Information (Micromedex)
- Donepezil Hydrochloride AHFS DI Monographs (ASHP)
No comments:
Post a Comment